Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Lorenzo Pacelli

Hand Surgery La Jolla, CA Medical Doctor

NPI 1457315178 CMS profile 111749

10666 N Torrey Pines Rd, La Jolla, CA 92037

Open in the dashboard

General payments

$46,007

138 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Lorenzo Pacelli of La Jolla, CA is reported in the CMS Open Payments database as having received $46,007 across 138 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Hand Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,519 16
2024 General $1,204 10
2023 General $4,132 20
2022 General $6,014 18
2021 General $10,881 25
2020 General $7,042 13
2019 General $15,215 36

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Lorenzo Pacelli
  • Hand Surgery median
  • Middle half of Hand Surgery
  • National median

In program year 2025, general payments to Lorenzo Pacelli were reported at $1,519. Among 1,842 Hand Surgery profiles paid that year, the median was $270 and the middle half received between $102 and $1,118.

Show as a table
Year Lorenzo Pacelli Hand Surgery median Middle half National median
2019 $15,215 $383 $106–$1,905 $163
2020 $7,042 $172 $51–$1,268 $114
2021 $10,881 $263 $71–$1,591 $132
2022 $6,014 $336 $87–$1,938 $149
2023 $4,132 $233 $81–$1,114 $160
2024 $1,204 $258 $88–$1,203 $164
2025 $1,519 $270 $102–$1,118 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Integra LifeSciences Corporation $16,601 26 payments
  2. In2Bones USA, LLC $9,366 17 payments
  3. Ensemble Orthopedics, Inc $6,466 30 payments
  4. ImpactOrtho, Inc. $4,057 4 payments
  5. Linvatec Corporation $2,757 11 payments
  6. Smith+Nephew, Inc. $2,749 8 payments
  7. Arthrex, Inc. $1,617 4 payments
  8. DePuy Synthes Sales Inc. $475 6 payments
  9. Stryker Corporation $367 3 payments
  10. Endo Pharmaceuticals Inc. $288 8 payments
  11. Other $1,265 21 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $14,011 30 payments
  2. Consulting Fee $13,299 9 payments
  3. Travel and Lodging $6,375 19 payments
  4. Food and Beverage $5,204 73 payments
  5. Education $4,917 6 payments
  6. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,200 1 payment
Products named General payments · program years 2019–2025
  1. FREEDOM WRIST Recon-Upper Extremity $8,302 18 payments
  2. TITAN-SHOULDER $8,302 18 payments
  3. EXTERNAL FIXATION SYSTEM $8,302 18 payments
  4. NUGRIP $8,204 7 payments
  5. REVERSE SHOULDER $7,086 6 payments
  6. Ensemble CMC $6,466 30 payments
  7. CoLink $6,459 6 payments
  8. CoLag $3,750 1 payment
  9. MCP $2,281 3 payments
  10. FREEDOM Wrist Extremity, Upper $2,244 2 payments
  11. Other $18,679 116 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

113

Median for Hand Surgery: 118

Drug cost

$634

Median for Hand Surgery: $615

Branded share of claims

0%

Median for Hand Surgery: 34.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Methylprednisolone Generic 36 $196
Gabapentin Generic 16 $177
Ibuprofen Generic 36 $152
Cefadroxil Generic 25 $109

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,399 Part D prescribers listed as Hand Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 117 billing codes

Paid by Medicare

$337,891

Of which drugs: $36,639

Medicare patients

895

Average age 75

Services billed

13,585

538 women, 357 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 68%
High blood pressure 59%
Ischemic heart disease 24%
Osteoporosis 21%
Depression 20%
Chronic kidney disease 17%
Diabetes 16%
Atrial fibrillation 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 303 1,126 $858
Injection, methylprednisolone acetate, 1 mg J1010 Office 136 5,535 $568
Injection, methylprednisolone acetate, 40 mg J1030 Office 26 29 $141
Injection, methylprednisolone acetate, 20 mg J1020 Office 16 17 $88
Injection, bupivicaine, not otherwise specified, 0.5 mg J0665 Office 22 3,559 $35

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

138 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Hand Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record